{"store":{"baseInfo":{"podcastTitle":"Tea Time with Tokio Marine HCC - Stop Loss Group","slug":"teatimewithtokiomarine","podcastDescription":"This podcast is brought to you by Tokio Marine HCC Stop Loss Group with its corporate office in Kennesaw, Georgia. Our vision is to bring quality information and value to our partners, our clients, our producers, and anyone who has a passion for stop loss, organ transplant, Taft Hartley, captive, and level-funded business.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/16273501/Tea_Time_2__kvzkrj.jpg","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16273501/Tea_Time_2__kvzkrj_1200x628.jpg?s=98e1d51e280165efa8479beab5e763f1&e=jpg","podcastUrl":"https://teatimewithtokiomarine.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/teatimewithtokiomarine/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pu/pbblog-9ixwn-f8505d","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":15,"gmtAdjustment":"GMT-05:00","useDaylightTime":1,"value":-5,"text":"(GMT-05:00) Eastern Time (US & Canada)","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"America/New_York"},"podcastDownloads":null,"totalEpisodes":3,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Tokio Marine HCC Stop Loss Group","engagementStatsBaseUrl":null,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-9ixwn-f8505d-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/us/podcast/tea-time-with-tokio-marine-hcc-stop-loss-group/id1682104867","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png","title":null},{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2Fteatimewithtokiomarine.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog16273501%26podcastIdTag%3D9ixwn&dfl=https%3A%2F%2Fteatimewithtokiomarine.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/3VDcbVFydpmM6iDppXorxV","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Arial"},{"id":"SecondaryFont","val":"Arial"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#EEEEEE"},{"id":"HomeHeaderBackgroundColor","val":"#0066CC"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/w3NMvEsqgu83","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-6j0mgLizDun3","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2023 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":null,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://teatimewithtokiomarine.podbean.com","apiCommonParams":{"t":"67906200","clientSignature":"f39d10d9a0f8ae1ad6806ced60770897","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb23522778-jnxu4","episode":{"id":"pb23522778","idTag":"jnxu4","title":"Cell and Gene Therapy","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/16273501/Tea_Time_2__kvzkrj_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16273501/Tea_Time_2__kvzkrj_1200x628.jpg?s=98e1d51e280165efa8479beab5e763f1&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/16273501/Tea_Time_2__kvzkrj.jpg","previewContent":null,"content":"

In this episode, recorded on June 13, 2023, David Grider is joined by Robby Kerr to discuss cell and gene therapy and how it ties in with the stop loss industry.

Send us your comments, questions, or topics you would like to hear about in future podcasts. Our email address is teatime@tmhcc.com.

","publishTimestamp":1721161057,"duration":687,"mediaUrl":"https://mcdn.podbean.com/mf/web/nznpvc52suebt8ge/Updated_Podcast3_mixdown.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-jnxu4-166edda","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-jnxu4-166edda","transcriptUrl":null,"permalink":"/e/cellandgenetherapy/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PB166EDDAJNXU4","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":104,"status":"publish","hasMoreContent":false,"chaptersUrl":null},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-jnxu4-166edda","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb23522778","idTag":"jnxu4","title":"Cell and Gene Therapy","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/16273501/Tea_Time_2__kvzkrj_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16273501/Tea_Time_2__kvzkrj_1200x628.jpg?s=98e1d51e280165efa8479beab5e763f1&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/16273501/Tea_Time_2__kvzkrj.jpg","previewContent":null,"content":"

In this episode, recorded on June 13, 2023, David Grider is joined by Robby Kerr to discuss cell and gene therapy and how it ties in with the stop loss industry.

Send us your comments, questions, or topics you would like to hear about in future podcasts. Our email address is teatime@tmhcc.com.

Cell and Gene Therapy

Comments (0)